Biomaterials to Neuroprotect the Stroke Brain: A Large Opportunity for Narrow Time Windows
Ischemic stroke represents one of the most prevalent pathologies in humans and is a leading cause of death and disability. Anti-thrombolytic therapy with tissue plasminogen activator (t-PA) and surgical thrombectomy are the primary treatments to recanalize occluded vessels and normalize the blood fl...
Main Authors: | Daniel González-Nieto, Rocío Fernández-Serra, José Pérez-Rigueiro, Fivos Panetsos, Ricardo Martinez-Murillo, Gustavo V. Guinea |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/5/1074 |
Similar Items
-
Understanding Why Post-Stroke Depression May Be the Norm Rather Than the Exception: The Anatomical and Neuroinflammatory Correlates of Post-Stroke Depression
by: Tissa Wijeratne, et al.
Published: (2021-04-01) -
Glutamate Scavenging as a Neuroreparative Strategy in Ischemic Stroke
by: Oykum Kaplan-Arabaci, et al.
Published: (2022-03-01) -
PSD-95: An Effective Target for Stroke Therapy Using Neuroprotective Peptides
by: Lola Ugalde-Triviño, et al.
Published: (2021-11-01) -
Prevention of excitotoxicity‐induced processing of BDNF receptor TrkB‐FL leads to stroke neuroprotection
by: Gonzalo S Tejeda, et al.
Published: (2019-07-01) -
Glutamate-releasing BEST1 channel is a new target for neuroprotection against ischemic stroke with wide time window
by: Shuai Xiong, et al.
Published: (2023-07-01)